Menu
Scroll to Top
Locations
Palo Alto, CA, USA
industry
Biotechnology · DeepTech · Health
Size
11-50 employees
Stage
Seed
founded in
2020
Interface Biosciences is a therapeutic platform company focused on developing next-generation immunotherapies by leveraging natural products derived from commensal microbes. Their innovative approach utilizes AI-guided search strategies to optimize multi-targeted immunotherapies for complex diseases such as autoimmune disorders and cancer. By mining natural product libraries, they aim to create safe and effective therapeutics with unprecedented stability and potency. The company is co-founded by Stanford PhDs and is positioned at the forefront of drug development, integrating biological evolution and modern machine learning to revolutionize treatment options.
Something looks off?On-site & Remote